Intrinsic Value of S&P & Nasdaq Contact Us

Palisade Bio, Inc. PALI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
34/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
-35.9%

Palisade Bio, Inc. (PALI) has 20 known insider and institutional holders on record. The largest holder is GARR RICHARD with 1,336,121 shares. Other notable holders include REGAL ONE CORP and JOHE KARL.

Over the last 12 months, insiders have made 22 transactions in PALI stock — 18 buys (valued at $17.76K) and 2 sells (valued at $10.3K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

PALI Insider Ownership

Top Holder
GARR RICHARD
1,336,121 shares
Buys (12 mo)
18
$17.76K value
Sells (12 mo)
2
$10.3K value
12-Month Transaction Activity
Buy 82%
Sell 9%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Garr Richard CEO 1,336,121 2015-11-03
100%
2 Regal One Corp 10 Percent Owner 1,293,911 2007-03-19
97%
3 Johe Karl Chief Scientific Officer 826,304 2015-11-16
62%
4 Smith Sandford D Director 219,916 2019-07-03
16%
5 Oldaker William Clyde Director 187,510 2019-07-03
14%
6 Conron John Chief Financial Officer 115,492 2011-02-03
9%
7 Sohn Catherine A. Director 106,952 2015-07-06
8%
8 Daly Richard J Chief Executive Officer 100,000 2017-11-09
7%
9 Chuang Emil Director 60,600 2025-11-06
5%
10 Wei Binxian Director 60,600 2025-11-06
5%
11 Westreich Stanley Director 59,660 2018-07-05
4%
12 Hallam Thomas Chief Executive Officer 40,000 2022-08-18
3%
13 Finley John David CEO, CFO 26,667 2026-02-13
2%
14 Jones Mitchell Lawrence Chief Medical Officer 15,252 2026-02-13
1%
15 Dawson Michael John Chief Medical Officer 15,000 2022-03-31
1%
16 Williams Donald Allen Director 10,728 2026-01-21
1%
17 Ogilvie Scott Varde Director 10,106 2019-10-11
1%
18 Lloyd Jones Jonathan Brian Chief Financial Officer 7,859 2017-03-27
1%
19 Mazzo David J Director 6,000 2021-04-26
0%
20 Trenschel Robert J. Director 5,820 2023-11-24
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-02-12 Jones Mitchell Lawrence Chief Medical Officer Informative Sell 1,989 $1.75 $3.48K
2026-02-11 Jones Mitchell Lawrence Chief Medical Officer Option Exercise 8,000 - -
2026-02-12 Finley John David CEO, CFO Informative Sell 3,896 $1.75 $6.82K
2026-02-11 Finley John David CEO, CFO Option Exercise (Sell) 13,333 - -
2026-02-09 Jones Mitchell Lawrence Chief Medical Officer RSU Award 787,000 - -
2026-02-09 Finley John David CEO, CFO RSU Award 2,011,000 - -
2026-01-16 Williams Donald Allen Director Informative Buy 5,000 $1.67 $8.36K
2026-01-09 Williams Donald Allen Director Informative Buy 5,000 $1.88 $9.4K
2025-10-06 Chuang Emil Director RSU Award 60,600 - -
2025-10-06 Wei Binxian Director RSU Award 60,600 - -
2025-10-06 Williams Donald Allen Director RSU Award 182,000 - -
2025-10-06 Jones Mitchell Lawrence Chief Medical Officer RSU Award 7,665,800 - -
2025-10-06 Chuang Emil Director RSU Award 510,700 - -
2025-10-06 Finley John David CEO, CFO RSU Award 9,179,400 - -
2025-10-06 Wei Binxian Director RSU Award 510,700 - -
2025-10-06 Williams Donald Allen Director RSU Award 1,538,700 - -
2025-09-04 Jones Mitchell Lawrence Chief Medical Officer RSU Award 289,000 - -
2025-09-04 Chuang Emil Director RSU Award 18,800 - -
2025-09-04 Finley John David CEO, CFO RSU Award 323,400 - -
2025-09-04 Wei Binxian Director RSU Award 18,800 - -
2025-09-04 Williams Donald Allen Director RSU Award 64,400 - -
2025-07-07 Chuang Emil Director Unknown - - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message